OncoResponse Awarded $13 Million in Funding from CPRIT and Raises $14 Million in Added Funds from Investors to Advance Cancer Immunotherapy - 5/18/2023
RiverVest led the Series A investment in Standard Bariatrics in 2018. The surgical device company was acquired by Teleflex, Inc. in 2022 for $170 million plus additional milestone payments.
(March 23, 2023) – For a venture capital firm to be successful, particularly in a difficult market environment as we have today, a firm can’t rely on luck or probabilities. It must have a sound strategy.
ST. LOUIS (September 7, 2022) – Good Therapeutics – a RiverVest Venture Fund IV portfolio company – has entered into a definitive merger agreement to be acquired by…
RiverVest strives to improve the lives of patients, support entrepreneurs, and earn the trust of investors through science, strategy, and innovation.Contact us at info@rivervest.com
Transparency in Coverage Rule: To access the machine-readable files created and published by United Healthcare, please click here.